News|Articles|February 19, 2020

Centogene to Host Events Highlighting Rare Disease Day

At the event, Centogene will also announce its plans to host the annual International Rare Disease Film Festival in Berlin in 2021.

Centogene, a Germany-based rare disease company focused on turning clinical, genetic, and biochemical data into medical solutions for physicians and pharmaceutical companies, announced it is highlighting Rare Disease Day on Feb. 29, 2020 with an event in Berlin, Germany. The company will also host simultaneous events in Mexico City, Mexico, and Lahore, Pakistan.

According to a Feb. 13, 2020 press release, the Berlin events will begin with a conference session featuring rare disease physicians, advocates, patients, and their families. Next, guests will be treated to musical performances from The Wave Quartet and Shake Stew before viewing entries from the DISORDER Film Festival that took place in San Francisco in November 2019.

At the event, Centogene will also announce its plans to host the annual International Rare Disease Film Festival in Berlin in 2021, according to the release.

"Art is the universal global language that can visualize emotions and reach people of all cultures," said Arndt Rolfs, founder and CEO of Centogene, in the press release. "Film in particular is ideally suited to encapsulating the complexity of the subject of rare diseases. We are excited to have incised the creative energy of high caliber artists for our film competition. This will help the topic of rare diseases gain the attention it deserves-after all, it affects over 350 million people worldwide."

Source: Centogene

 

 


Related to this article

Trophy and confetti on light background, top view with space for text. Victory concept | Image Credit: ©New Africa -stock.adobe.com
The winners of the CPHI Pharma Awards 2026 include a neurodegeneration platform, a track-and-trace packaging innovation, a enzymatic mRNA manufacturing technology, and a cell-free enzymatic biomanufacturing platform.
PharmTech Weekly Roundup—October 2, 2026
This week on PharmTech, Merck diversified its pipeline, USP emphasizes supply chain security, AI systems are examined, and speakers preview their presentations at CPHI Milan and AAPS PharmSci 360.